• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物标志物在肝硬化继发急性肾损伤诊断中的疗效。

The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.

机构信息

Department of Laboratory Medicine, Mianyang Central Hospital, Affiliated to Southwest Medical University, Mianyang.

Department of Laboratory Medicine, Pidu District People's Hospital, Chengdu, Sichuan, China.

出版信息

Medicine (Baltimore). 2021 Apr 9;100(14):e25411. doi: 10.1097/MD.0000000000025411.

DOI:10.1097/MD.0000000000025411
PMID:33832138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036071/
Abstract

This study is to investigate the role of neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (CysC) and creatinine in the diagnosis of acute kidney injury (AKI) secondary to liver cirrhosis.A total of 825 patients (including 540 liver cirrhosis patients and 285 healthy controls) were enrolled. Liver cirrhosis patients were further subdivided into AKI secondary to liver cirrhosis group (AKI group, 210 patients) and simple liver cirrhosis group (LC group, 330 patients). Serum NGAL/urine NGAL (sNGAL/uNGAL), and serum creatinine (sCr) levels as well as estimated glomerular filtration rates were measured. The diagnostic performances of these indicators in AKI secondary to liver cirrhosis were evaluated.The levels of sNGAL, uNGAL, CysC and sCr in the AKI group were significantly higher than those of LC and healthy control groups. However, the eGFR and c-aGFR of AKI group were significantly lower. With the progression of AKI (AKI-S1→AKI-S2→AKI-S3), the levels of sNGAL, uNGAL, CysC and sCr increased gradually, while the levels of c-aGFR and eGFR decreased gradually. The sNGAL, uNGAL and CysC were positively correlated with sCr (r = 0.638, 0.635, and 0.650), but negatively correlated with c-aGFR (r = -0.617, -0.606 and -0.655). However, eGFR had a negative correlation with sCr (r = -0.711), but a positive correlation with c-aGFR (r = 0.736). ROC curve analysis showed that the area under the curve for uNGAL was the largest (0.976), followed by sNGAL (0.967). The diagnostic efficacy of uNGAL and sNGAL in AKI group were 0.907 and 0.870, and the risk degrees were OR = 54.524 and 5.115, respectively.NGAL might perform better than sCr and CysC in the diagnosis of AKI secondary to liver cirrhosis, while uNGAL might be a better indicator than sNGAL in AKI diagnosis.

摘要

本研究旨在探讨中性粒细胞明胶酶相关载脂蛋白(NGAL)、胱抑素 C(CysC)和肌酐在诊断肝硬化继发急性肾损伤(AKI)中的作用。共纳入 825 例患者(包括 540 例肝硬化患者和 285 例健康对照者)。肝硬化患者进一步分为肝硬化继发 AKI 组(AKI 组,210 例)和单纯肝硬化组(LC 组,330 例)。检测血清 NGAL/尿 NGAL(sNGAL/uNGAL)和血清肌酐(sCr)水平及估算肾小球滤过率(eGFR)。评估这些指标在诊断肝硬化继发 AKI 中的诊断性能。AKI 组的 sNGAL、uNGAL、CysC 和 sCr 水平明显高于 LC 组和健康对照组。然而,AKI 组的 eGFR 和 c-aGFR 明显降低。随着 AKI 的进展(AKI-S1→AKI-S2→AKI-S3),sNGAL、uNGAL、CysC 和 sCr 水平逐渐升高,而 c-aGFR 和 eGFR 水平逐渐降低。sNGAL、uNGAL 和 CysC 与 sCr 呈正相关(r = 0.638、0.635 和 0.650),与 c-aGFR 呈负相关(r = -0.617、-0.606 和 -0.655)。然而,eGFR 与 sCr 呈负相关(r = -0.711),与 c-aGFR 呈正相关(r = 0.736)。ROC 曲线分析显示,uNGAL 的曲线下面积最大(0.976),其次是 sNGAL(0.967)。uNGAL 和 sNGAL 在 AKI 组中的诊断效能分别为 0.907 和 0.870,风险度分别为 OR = 54.524 和 5.115。NGAL 可能比 sCr 和 CysC 更能诊断肝硬化继发 AKI,而 uNGAL 可能比 sNGAL 更能诊断 AKI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/8df16cea93a2/medi-100-e25411-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/ec898d2205c9/medi-100-e25411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/74284e024232/medi-100-e25411-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/31f5c9887a34/medi-100-e25411-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/8df16cea93a2/medi-100-e25411-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/ec898d2205c9/medi-100-e25411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/74284e024232/medi-100-e25411-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/31f5c9887a34/medi-100-e25411-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1588/8036071/8df16cea93a2/medi-100-e25411-g004.jpg

相似文献

1
The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.生物标志物在肝硬化继发急性肾损伤诊断中的疗效。
Medicine (Baltimore). 2021 Apr 9;100(14):e25411. doi: 10.1097/MD.0000000000025411.
2
Neutrophil gelatinase associated lipocalin as an indicator of acute kidney injury and inflammation in burned children.中性粒细胞明胶酶相关脂质运载蛋白作为烧伤儿童急性肾损伤和炎症的指标
Burns. 2014 Jun;40(4):648-54. doi: 10.1016/j.burns.2013.09.004. Epub 2013 Sep 21.
3
Comparison of urine and serum neutrophil gelatinase-associated lipocalin after open and endovascular thoraco-abdominal aortic surgery and their meaning as indicators of acute kidney injury.开放手术和血管腔内修复胸腹主动脉手术后尿和血清中性粒细胞明胶酶相关脂质运载蛋白的比较及其作为急性肾损伤指标的意义
Vasa. 2019 Jan;48(1):79-87. doi: 10.1024/0301-1526/a000736. Epub 2018 Sep 10.
4
Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans.中性粒细胞明胶酶相关脂质运载蛋白作为动脉硬化闭塞症血管内治疗后对比剂肾病的早期预测指标
Medicine (Baltimore). 2020 Sep 11;99(37):e21386. doi: 10.1097/MD.0000000000021386.
5
Neutrophil gelatinase-associated lipocalin and acute kidney injury in endovascular aneurysm repair or open aortic repair: a pilot study.中性粒细胞明胶酶相关脂质运载蛋白与血管内动脉瘤修复或开放主动脉修复术后急性肾损伤:一项初步研究。
Biochem Med (Zagreb). 2018 Feb 15;28(1):010904. doi: 10.11613/BM.2018.010904. Epub 2018 Jan 10.
6
Serum and urine acute kidney injury biomarkers in asphyxiated neonates.窒息新生儿的血清和尿液急性肾损伤生物标志物。
Pediatr Nephrol. 2012 Sep;27(9):1575-82. doi: 10.1007/s00467-012-2162-4. Epub 2012 Apr 25.
7
Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis.尿肾损伤分子-1(KIM-1)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)联合血清胱抑素 C 对预测肝硬化失代偿继发急性肾损伤的价值。
Sci Rep. 2018 May 21;8(1):7962. doi: 10.1038/s41598-018-26226-6.
8
Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.中性粒细胞明胶酶相关脂质运载蛋白作为择期侵入性心脏手术后造影剂诱导的肾病的早期标志物
Clin Cardiol. 2016 Aug;39(8):464-70. doi: 10.1002/clc.22551. Epub 2016 May 13.
9
Detection of acute kidney injury in premature asphyxiated neonates by serum neutrophil gelatinase-associated lipocalin (sNGAL)--sensitivity and specificity of a potential new biomarker.血清中性粒细胞明胶酶相关脂质运载蛋白(sNGAL)检测早产窒息新生儿急性肾损伤——一种潜在新生物标志物的敏感性和特异性
Biochem Med (Zagreb). 2015 Oct 15;25(3):450-9. doi: 10.11613/BM.2015.046. eCollection 2015.
10
Value of urine/serum Neutrophil gelatinase-associated lipocalin ratio in distinguishing acute kidney injury from chronic kidney disease.尿/血清中性粒细胞明胶酶相关脂质运载蛋白比值在鉴别急性肾损伤与慢性肾脏病中的价值。
Clin Chim Acta. 2022 Feb 1;526:23-29. doi: 10.1016/j.cca.2021.12.018. Epub 2021 Dec 24.

引用本文的文献

1
Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?新型生物标志物能否有效预测肝或肾移植受者的急性肾损伤?
Int J Mol Sci. 2024 Nov 10;25(22):12072. doi: 10.3390/ijms252212072.
2
Seeing and Sensing the Hepatorenal Syndrome (HRS): The Growing Role of Ultrasound-Based Techniques as Non-Invasive Tools for the Diagnosis of HRS.观察与感知肝肾综合征(HRS):基于超声的技术作为HRS诊断的非侵入性工具的作用日益凸显。
Diagnostics (Basel). 2024 Apr 30;14(9):938. doi: 10.3390/diagnostics14090938.
3
Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis.

本文引用的文献

1
Biomarkers of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.心脏手术后急性肾损伤的生物标志物:叙述性综述。
Biomed Res Int. 2019 Jun 27;2019:7298635. doi: 10.1155/2019/7298635. eCollection 2019.
2
Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes.通过血清肌酐、胱抑素C和β2-微球蛋白估算老年人的肾小球滤过率:1型糖尿病加拿大长寿研究结果
Kidney Int Rep. 2019 Feb 21;4(6):786-796. doi: 10.1016/j.ekir.2019.02.010. eCollection 2019 Jun.
3
Vasoconstrictors in hepatorenal syndrome - A critical review.
肝硬化患者的急性肾损伤和肝肾综合征
J Clin Med. 2023 Dec 29;13(1):199. doi: 10.3390/jcm13010199.
4
Variations of urinary N-acetyl-β-D-glucosaminidase levels and its performance in detecting acute kidney injury under different thyroid hormones levels: a prospectively recruited, observational study.尿 N-乙酰-β-D-氨基葡萄糖苷酶水平的变化及其在不同甲状腺激素水平下检测急性肾损伤的性能:一项前瞻性招募、观察性研究。
BMJ Open. 2022 Mar 3;12(3):e055787. doi: 10.1136/bmjopen-2021-055787.
肝肾综合征中的血管收缩剂——批判性综述。
Ann Hepatol. 2019 Mar-Apr;18(2):287-290. doi: 10.1016/j.aohep.2018.12.002. Epub 2019 Apr 16.
4
Comparison of different equations for estimated glomerular filtration rate in Han Chinese patients with chronic kidney disease.中国汉族慢性肾脏病患者中不同估算肾小球滤过率方程的比较。
Clin Nephrol. 2019 May;91(5):301-310. doi: 10.5414/CN109420.
5
Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.肾功能损害与肝硬化患者死亡率增加相关:一项回顾性队列研究。
Medicine (Baltimore). 2019 Feb;98(6):e14475. doi: 10.1097/MD.0000000000014475.
6
Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review.基于胱抑素 C 与肌酐预测药物肾清除率:系统评价。
Mayo Clin Proc. 2019 Mar;94(3):500-514. doi: 10.1016/j.mayocp.2018.08.002. Epub 2019 Jan 31.
7
Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.尿中性粒细胞明胶酶相关脂质运载蛋白和血清胱抑素C在一组肝硬化合并肾功能不全患者中的临床应用:肝肾综合征诊断中的挑战
Eur J Gastroenterol Hepatol. 2019 Jun;31(6):692-702. doi: 10.1097/MEG.0000000000001347.
8
Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury.急性和慢性肾损伤的特征是转录和表观遗传改变的不同模式。
Sci Rep. 2018 Dec 14;8(1):17870. doi: 10.1038/s41598-018-35943-x.
9
Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.血清胱抑素 C 和尿 N-乙酰-β-D-氨基葡萄糖苷酶评估和预测失代偿期肝硬化患者的急性肾损伤。
J Gastroenterol Hepatol. 2019 Jan;34(1):234-240. doi: 10.1111/jgh.14387. Epub 2018 Aug 21.
10
Utility of cystatin C-based equations in patients undergoing dialysis.胱抑素 C 方程在透析患者中的应用。
Clin Chim Acta. 2018 Oct;485:282-287. doi: 10.1016/j.cca.2018.07.010. Epub 2018 Jul 10.